1-7 of 7
Andrea Schietinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B031: TCR signal strength drives tumor-specific CD8 T cell differentiation

Sandra Carson, Andrea Schietinger
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10_Supplement): B031.
https://doi.org/10.1158/2326-6074.TUMIMM24-B031
Published: 18 October 2024
View article titled, Abstract B031: TCR signal strength drives tumor-specific CD8 T cell differentiation
Journal Articles

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

Maryam Pourmaleki, Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete, Yanyun Li, Mianlei Zhang, Subhiksha Nandakumar, Carl Campos, Saad Nadeem, David S. Klimstra, Claire F. Temple-Oberle, Thomas Brenn, Evan J. Lipson, Kara M. Schenk, Julie E. Stein, Janis M. Taube, Michael G. White, Raymond Traweek, Jennifer A. Wargo, John M. Kirkwood, Billel Gasmi, Stephanie L. Goff, Alex D. Corwin, Elizabeth McDonough, Fiona Ginty, Margaret K. Callahan, Andrea Schietinger, Nicholas D. Socci, Ingo K. Mellinghoff, Travis J. Hollmann
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (3): 303–313.
https://doi.org/10.1158/2326-6066.CIR-21-1083
Published: 01 March 2022
View article titled, Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
Open the PDF for Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract IA14: Molecular programs defining tumor-specific T-cell dysfunction and reprogrammability

Andrea Schietinger
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): IA14.
https://doi.org/10.1158/2326-6074.TUMIMM19-IA14
Published: 02 March 2020
View article titled, Abstract IA14: Molecular programs defining tumor-specific T-cell dysfunction and reprogrammability
Journal Articles

Abstract A215: Thymocyte selection-associated HMG box protein TOX is a master regulator of tumor-specific T-cell dysfunction

Andrew C. Scott, Steven Camara, Peter Lauer, Alexandra Synder, Dmitriy Zamarin, Tyler Walther, Olivier Levy, Michael Glickman, Jonathan Kaye, Mary Philip, Andrea Schietinger
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A215.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A215
Published: 01 February 2019
View article titled, Abstract A215: Thymocyte selection-associated HMG box protein TOX is a master regulator of tumor-specific T-cell dysfunction
Journal Articles

Abstract IA01: Engineering T cell responses to tumors: Taking the immune system where no responses have gone before

Philip D. Greenberg, Kristin G. Anderson, Dan Egan, Sunil R. Hingorani, Shannon K. Oda, Rachel Perret, Andrea Schietinger, Tom M. Schmitt, Ingunn M. Stromnes, Alec Wilkens, Aude G. Chapuis
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): IA01.
https://doi.org/10.1158/2326-6066.IMM2016-IA01
Published: 31 October 2016
View article titled, Abstract IA01: Engineering T cell responses to tumors: Taking the immune system where no responses have gone before
Journal Articles

Abstract A093: Impact of antigen affinity on T cell dysfunction in solid tumors

Mojdeh Shakiba, Mary Philip, Andrea Schietinger
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): A093.
https://doi.org/10.1158/2326-6066.IMM2016-A093
Published: 31 October 2016
View article titled, Abstract A093: Impact of antigen affinity on T cell dysfunction in solid tumors
Journal Articles

Abstract PR09: Identifying the epigenetic code of tumor-specific CD8 T cell dysfunction and therapeutic reprogramming

Mary Philip, Lauren Fairchild, Liping Sun, Agnes Viale, Steven Camara, Ellen Horste, Taha Merghoub, Jedd D. Wolchok, Christina S. Leslie, Andrea Schietinger
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): PR09.
https://doi.org/10.1158/2326-6066.IMM2016-PR09
Published: 31 October 2016
View article titled, Abstract PR09: Identifying the epigenetic code of tumor-specific CD8 T cell dysfunction and therapeutic reprogramming